Evidence map›Paper›PMID 32430839›Full record

ArticleEuropean journal of epidemiology2020

Number of prior negative screening outcomes does not influence future risk of breast cancer.

Marie Lilleborge, Ragnhild S Falk, Solveig Hofvind

Open access · hybridAbstract read
In one paragraph

Article in European journal of epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Marie LilleborgeSection for Breast Cancer Screening, Cancer Registry of Norway, Postbox 5313, Majorstuen, 0304, Oslo, Norway. Marie.Lilleborge@Kreftregisteret.no.ORCID http://orcid.org/0000-0003-3089-7851
Ragnhild S FalkOslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-8398-3492
Solveig HofvindSection for Breast Cancer Screening, Cancer Registry of Norway, Postbox 5313, Majorstuen, 0304, Oslo, Norway.ORCID http://orcid.org/0000-0003-0178-8939
Cancer Registry of Norway · NOOsloMet – Oslo Metropolitan University · NOOslo University Hospital · NO

Funding

Kreftforeningen 5746604
6 · The paper itself

Abstract

We questioned whether a history of negative screening outcomes could be used to predict breast cancer risk, and thus be used as a potential factor for stratification of mammographic screening. Data from the Norwegian population based breast cancer screening program, BreastScreen Norway, was used to estimate cumulative hazard rates for breast cancer by number of prior negative screening outcomes among participants from 1995 through 2016. We followed three age cohorts of women, who started screening at age 50-54, 55-59, and 60-64 years. Further, we estimated the absolute and relative risk of breast cancer by number of prior negative screening outcomes. The cumulative hazard curves were parallel for all numbers of negative screening outcomes for all age cohorts. The absolute risk of breast cancer increased with number of negative screening outcomes for the youngest age cohort. For the oldest age cohorts, the absolute risk was stable during the screening period and decreased thereafter. The number of negative screening outcomes was not associated with risk of breast cancer, adjusted for age, percent screening attendance and calendar years (HR 1.00, 95% CI 0.98-1.02). Our results suggest that the number of negative screening outcomes does not predict breast cancer risk among participants in BreastScreen Norway.

Indexed as

AdultBreast NeoplasmsEarly Detection of CancerFemaleFollow-Up StudiesHumansMammographyMass ScreeningMiddle AgedNorwayPredictive Value of TestsRiskRisk AssessmentBreast cancerMammographyRisk assessmentScreening history

Identifiers

PMID32430839
PMCPMC7320949
OpenAlexW3026307750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.